Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.33 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840750 | 0.92 | GABRA1 (0.64) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5174936 | 0.89 | GABRA1 (0.61) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5174943 | 0.89 | GABRA1 (0.61) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6547312 | 0.89 | GABRA1 (0.47) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 | |
| Hydrogen Peroxide SCHEMBL5685702 | 0.86 | GABRA1 (0.65) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8124571 | 0.86 | GABRA1 (0.48) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL10525253 | 0.86 | GABRA1 (0.54) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11464452 | 0.84 | GABRA1 (0.56) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL21913441 | 0.83 | TAAR1 (0.55) | GABRA1GABRB2SLC6A2TAAR1SIGMAR1 | |
| SCHEMBL8128253 | 0.83 | GABRA1 (0.45) | GABRA1GABRB2SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0470651-A1 | 1,2-Di(4-isobutylphenyl) ethane and its preparation and use as intermediate | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1992-02-12 | — | — | EP | disclosed |
| EP-0290050-B1 | METHOD FOR PRODUCING ALKYLSTYRENE | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1991-08-21 | — | — | EP | disclosed |
| US-5026939-A | Cracking 1,2-di(4-isobutylphenyl)ethane in contact with acid catalyst | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1991-06-25 | — | — | US | disclosed |
| US-4885419-A | IBUPROFEN | NIPPON PETROCHEMICALS COMPANY, LTD. (JP) | 1989-12-05 | — | — | US | disclosed |
| EP-0290050-A1 | Method for producing alkylstyrene | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1988-11-09 | — | — | EP | disclosed |